The prevalence of neuroendocrine neoplasms in Norway

#3474

Introduction: Neuroendocrine neoplasms (NEN) are a heterogeneous group of tumors originating from neuroendocrine cells comprising of neuroendocrine tumors (NET) and neuroendocrine carcinomas (NEC).

Aim(s): To investigate the prevalence of NEN in Norway.

Materials and methods: The prevalence and incidence of NEN were investigated through the Cancer Registry of Norway that has a completeness of 98.8%. All inhabitants have a unique identification number ensuring unequivocal identification. Disease information is received from several sources, such as clinician reports, pathology and autopsy reports and death certificates. Prevalence is reported as complete prevalence, which represents the proportion of people alive on a certain day who have been diagnosed with the disease, regardless of how long ago the diagnosis was made, and regardless whether they have been cured for their malignancy. This definition is based on the standard of the U.S. Cancer institute. The reported prevalence is for 31. Dec 2019. The population of Norway at that time was 5.367.500 persons.

Conference:

Presenting Author:

Authors: Thiis-Evensen E, Åvitsland T, Sponheim J,

Keywords: Prevalence, incidence, neuroendocrine neoplasm, neuroendocrine tumor, neuroendocrine carcinoma, epidemiology,